During the past decade, Mercy Health Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 24 clinical trials were completed, i.e. on average, 171.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 12 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Health Research" #1 sponsor was "Pfizer" with 12 trials, followed by "Amgen" with 6 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored and "Boston Scientific Corporation" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Health Research" #1 collaborator was "Novartis" with 3 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Synteract, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Health Research" are "Migraine" (6 trials), "Osteoarthritis" (5 trials), "Arthritis" (3 trials), "Major Depressive Disorder" (3 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Mercy Health Research" in a lesser frequency.

Most popular intervention types in "Mercy Health Research" are "Drug" (36 trials), "Biological" (10 trials), "Device" (5 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "placebo" (4 trials), "tanezumab" (3 trials), "Erenumab Dose 1" (2 trials) and "Erenumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Health Research" are 44 trials for "All" genders.

Currently, there are NaN active trials in "Mercy Health Research". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Mercy Health Research, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Health Research, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 5 trials that are defined as “Not Applicable".